DP VII Associates L.P., 10% Owner at Orexigen Therapeutics, Inc. (OREX), bought 6,926 shares at $7.85 ($55K) on 2009-08-13, disclosed to the SEC on 2009-08-14.
Open-market purchase of $55k OREX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 6,708 | $54K | 96.9% |
| 2 | $7.85 | 218 | $2K | 3.1% |
| Total | $8.00 avg | 6,926 | $55K | 100% |
| Filing → |
| EVOK | SELL | 2016-04-21 | $4K | — | Filing → |
| EVOK | SELL | 2016-04-08 | $5K | — | Filing → |
| ESPR | BUY | 2013-07-02 | $67K | — | Filing → |